| Author | Stathis, Anastasios | dc.contributor.author |
| Author | Mey, Ulrich | dc.contributor.author |
| Author | Schär, Sämi | dc.contributor.author |
| Author | Hitz, Felicitas | dc.contributor.author |
| Author | Pott, Christiane | dc.contributor.author |
| Author | Mach, Nicolas | dc.contributor.author |
| Author | Krasniqi, Fatime | dc.contributor.author |
| Author | Novak, Urban | dc.contributor.author |
| Author | Schmidt, Christian | dc.contributor.author |
| Author | Hohloch, Karin | dc.contributor.author |
| Author | Kienle, Dirk Lars | dc.contributor.author |
| Author | Hess, Dagmar | dc.contributor.author |
| Author | Moccia, Alden A. | dc.contributor.author |
| Author | Unterhalt, Michael | dc.contributor.author |
| Author | Eckhardt, Katrin | dc.contributor.author |
| Author | Hayoz, Stefanie | dc.contributor.author |
| Author | Forestieri, Gabriela | dc.contributor.author |
| Author | Rossi, Davide | dc.contributor.author |
| Author | Dirnhofer, Stefan | dc.contributor.author |
| Author | Ceriani, Luca | dc.contributor.author |
| Author | Sartori, Giulio | dc.contributor.author |
| Author | Bertoni, Francesco | dc.contributor.author |
| Author | Buske, Christian | dc.contributor.author |
| Author | Zucca, Emanuele | dc.contributor.author |
| Author | Hiddemann, Wolfgang | dc.contributor.author |
| Date of accession | 2022-10-07T05:15:22Z | dc.date.accessioned |
| Available in OPARU since | 2022-10-07T05:15:22Z | dc.date.available |
| Date of first publication | 2022 | dc.date.issued |
| Language | en | dc.language.iso |
| Publisher | Universität Ulm | dc.publisher |
| Keyword | NON-HODGKIN-LYMPHOMA | dc.subject |
| Keyword | 1ST-LINE TREATMENT | dc.subject |
| Keyword | BENDAMUSTINE-RITUXIMAB | dc.subject |
| Keyword | RESPONSE ASSESSMENT | dc.subject |
| Keyword | TUMOR BURDEN | dc.subject |
| Keyword | INDOLENT | dc.subject |
| Keyword | IBRUTINIB | dc.subject |
| Keyword | BCL2 | dc.subject |
| Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
| Title | SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma | dc.title |
| Resource type | Wissenschaftlicher Artikel | dc.type |
| Institution | UKU. Institut für Experimentelle Tumorforschung | uulm.affiliationSpecific |
| DCMI Type | Text | uulm.typeDCMI |
| Category | Publikationsnachweise | uulm.category |
| DOI (external) | 10.1182/bloodadvances.2021006520 | dc.identifier.doiExternal |
| Source - Title of source | Blood Advances | source.title |
| Source - Place of publication | Elsevier | source.publisher |
| Source - Volume | 6 | source.volume |
| Source - Issue | 13 | source.issue |
| Source - Year | 2022 | source.year |
| Source - From page | 3911 | source.fromPage |
| Source - To page | 3920 | source.toPage |
| Source - ISSN | 2473-9529 | source.identifier.issn |
| Source - eISSN | 2473-9537 | source.identifier.eissn |
| Open Access | Green Published, gold | uulm.OA |
| Community | Universität Ulm / Medizin | uulm.community |
| WoS | 000836028000011 | uulm.identifier.wos |
| Bibliography | uulm | uulm.bibliographie |
